Table 3

The laboratory findings for safety after the duration of the clinical trial
Turmeric group (n = 26) Placebo group (n = 22) P-value1)
Baseline 12 week Baseline 12 week
WBC (×103/μl) 6.8 ± 1.7 6.7 ± 1.7 6.2 ± 1.4 6.2 ± 1.4 0.79
RBC (×1003/μl) 5.1 ± 0.3 5.1 ± 0.4 5.0 ± 0.3 5.0 ± 0.3 0.36
Hemoglobin (g/dL) 15.9 ± 1.1 15.9 ± 1.2 15.6 ± 1.4 15.7 ± 1.3 0.21
Hematocrit (%) 45.9 ± 2.9 46.0 ± 3.4 44.8 ± 2.9 45.4 ± 3.0 0.37
Platelet (×103/μl) 252.2 ± 49.3 250.3 ± 44.3 255.6 ± 58.5 254.5 ± 62.7 0.92
Total cholesterol (mg/dl) 193.6 ± 25.2 201.7 ± 30.0 194.2 ± 34.7 198.6 ± 31.7 0.62
Triglyceride (mg/dL) 213.3 ± 114.4 220.9 ± 132.8 172.8 ± 78.0 209.4 ± 167.6 0.44
HDL-cholesterol (mg/dL) 44.1 ± 11.8 43.69 ± 11.2 45.8 ± 10.2 48.5 ± 12.1 0.16
LDL-cholesterol (mg/dL) 122.5 ± 29.4 117.3 ± 27.6 125.9 ± 38.9 113.6 ± 27.5 0.33
Glucose (mg/dL) 91.9 ± 9.7 93.0 ± 12.6 90.1 ± 8.7 89.6 ± 8.7 0.52
Total Protein (g/dL) 7.4 ± 0.3 7.48 ± 0.4 7.3 ± 0.4 7.4 ± 0.4 0.73
Albumin (g/dL) 4.6 ± 0.2 4.63 ± 0.2 4.57 ± 0.2 4.6 ± 0.3 0.79
BUN (mg/dL) 14.5 ± 4.7 13.5 ± 3.6 13.3 ± 2.6 12.9 ± 2.8 0.58
Creatinine (mg/dL) 0.85 ± 0.13 0.81 ± 0.14 0.81 ± 0.14 0.83 ± 0.14 0.12

Values are presented as mean ± SD.

1) Linear mixed model for repeated measures data.

Kim et al.

Kim et al. BMC Complementary and Alternative Medicine 2013 13:58   doi:10.1186/1472-6882-13-58

Open Data